Pseudomembranous invasive tracheobronchial aspergillosis in an apparently immunocompetent patient with necrotizing pneumonia: a case report and brief review of the literature

Invasive tracheobronchial aspergillosis (ITBA) is a rare but life-threatening form of invasive pulmonary aspergillosis predominantly involving the tracheobronchial tree. Although commonly associated with immunocompromised states, ITBA has increasingly been reported in patients without classic host risk factors. Optimal treatment for refractory ITBA remains unclear. A 57-year-old woman presented with persistent fever, productive cough, pleuritic chest pain, wheezing, and respiratory failure after 12 days of treatment for Klebsiella pneumoniae pneumonia. She had no history of malignancy, transplantation, HIV infection, or chronic lung disease. Chest computed tomography revealed multifocal peribronchovascular consolidations with cavitary necrosis, diffuse bronchial wall thickening, and tree-in-bud nodules suggestive of invasive airway infection. Bronchoscopy demonstrated diffuse white pseudomembranes, friable mucosa, and purulent secretions throughout the tracheobronchial tree. Bronchoalveolar lavage microscopy showed filamentous fungi, and culture grew Aspergillus fumigatus . During initial antibacterial and oral voriconazole treatment, the patient remained dyspneic with high oxygen requirements despite declining inflammatory markers. Intravenous anidulafungin was added on hospital day 10 for suspected refractory ITBA. Clinical and radiological improvement subsequently occurred during concurrent antibacterial and combination antifungal treatment. The patient was discharged after 22 days and completed 20 weeks of voriconazole therapy. Follow-up CT showed further improvement. ITBA may occur in patients without recognized immunosuppressive conditions and should be considered in cases of invasive airway infection. Bronchoscopy is essential for early diagnosis, and combination therapy with voriconazole plus anidulafungin may be considered in selected patients with suspected refractory ITBA, although concurrent treatments limit interpretation of the response in this case.

Authors

Institutions

Publication Details

Journal
Egyptian Journal of Bronchology
Published
2026-11-18
DOI
https://doi.org/10.1186/s43168-026-00723-z
Primary Topic
Antifungal resistance and susceptibility
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Pseudomembranous invasive tracheobronchial aspergillosis in an apparently immunocompetent patient with necrotizing pneumonia: a case report and brief review of the literature

Thong Dang-Vu, Khoa Nguyen-Dang, Quoc‐Khanh Tran‐Le, Dung Lam-Quoc et al.
2 links
Egyptian Journal of Bronchology
Antifungal resistance and susceptibility
article

Pseudomembranous invasive tracheobronchial aspergillosis in an apparently immunocompetent patient with necrotizing pneumonia: a case report and brief review of the literature

Thong Dang-Vu, Khoa Nguyen-Dang, Quoc‐Khanh Tran‐Le, Dung Lam-Quoc, Nguyen Tran-Ngoc, Ngoc Duong-Minh, Tuan Cao-Thanh
article en

Abstract

Invasive tracheobronchial aspergillosis (ITBA) is a rare but life-threatening form of invasive pulmonary aspergillosis predominantly involving the tracheobronchial tree. Although commonly associated with immunocompromised states, ITBA has increasingly been reported in patients without classic host risk factors. Optimal treatment for refractory ITBA remains unclear. A 57-year-old woman presented with persistent fever, productive cough, pleuritic chest pain, wheezing, and respiratory failure after 12 days of treatment for Klebsiella pneumoniae pneumonia. She had no history of malignancy, transplantation, HIV infection, or chronic lung disease. Chest computed tomography revealed multifocal peribronchovascular consolidations with cavitary necrosis, diffuse bronchial wall thickening, and tree-in-bud nodules suggestive of invasive airway infection. Bronchoscopy demonstrated diffuse white pseudomembranes, friable mucosa, and purulent secretions throughout the tracheobronchial tree. Bronchoalveolar lavage microscopy showed filamentous fungi, and culture grew Aspergillus fumigatus . During initial antibacterial and oral voriconazole treatment, the patient remained dyspneic with high oxygen requirements despite declining inflammatory markers. Intravenous anidulafungin was added on hospital day 10 for suspected refractory ITBA. Clinical and radiological improvement subsequently occurred during concurrent antibacterial and combination antifungal treatment. The patient was discharged after 22 days and completed 20 weeks of voriconazole therapy. Follow-up CT showed further improvement. ITBA may occur in patients without recognized immunosuppressive conditions and should be considered in cases of invasive airway infection. Bronchoscopy is essential for early diagnosis, and combination therapy with voriconazole plus anidulafungin may be considered in selected patients with suspected refractory ITBA, although concurrent treatments limit interpretation of the response in this case.

Egyptian Journal of BronchologyVol. 20(1)
Cho Ray Hospital (VN), University of Medicine and Pharmacy at Ho Chi Minh City (VN), University Medical Center HCMC (VN)
Good health and well-being
Antifungal resistance and susceptibility
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon